Loading your page…
Each register with its number of medicines and a few of them.
Anvisa · 102 medicines
AEMPS · 85 medicines
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
AIFA · 76 medicines
CBG-MEB · 42 medicines
Health Canada · 23 medicines
FDA · 23 medicines
HALMED · 15 medicines
ALIMS · 12 medicines
MS · 7 medicines · Historical list
HSA · 7 medicines
TFDA · 7 medicines
SFDA · 4 medicines · Historical list
EMA · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
23 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Drospirenone | United States | 3.5MG | tablet, chewable | Not marketed | Exeltis USA INC |
| Drospirenone | United States | 4MG | tablet | Tentative approval | Lupin LTD |
| Drospirenone and Ethinyl EstradiolCombination | United States | 3MG; 0.03MG | tablet | Marketed | Lupin LTD |
| Drospirenone and Ethinyl EstradiolCombination | United States | 3MG; 0.02MG | tablet | Marketed | Hetero Labs |
| Drospirenone and EstradiolCombination | United States | 0.5MG; 1MG | tablet | Marketed | Novast Labs |
| Drospirenone, Ethinyl Estradiol and Levomefolate CalciumCombination | United States | 3MG,N/A; 0.02MG,N/A; 0.451MG,0.451MG, 3MG,N/A; 0.03MG,N/A; 0.451MG,0.451MG | tablet | Marketed | Lupin |
| ZumandimineCombination | United States | 3MG; 0.03MG | tablet | Marketed | Aurobindo Pharma LTD |
| Lo-ZumandimineCombination | United States | 3MG; 0.02MG | tablet | Marketed | Aurobindo Pharma LTD |
| AngeliqCombination | United States | 0.25MG; 0.5MG, 0.5MG; 1MG | tablet | Marketed | Bayer Hlthcare |
| BeyazCombination | United States | 3MG,N/A; 0.02MG,N/A; 0.451MG,0.451MG | tablet | Marketed | Bayer Hlthcare |
| LorynaCombination | United States | 3MG; 0.02MG | tablet | Marketed | Xiromed |
| NextstellisCombination | United States | 3MG; 14.2MG | tablet | Marketed | Mayne Pharma |
| SafyralCombination | United States | 3MG,N/A; 0.03MG,N/A; 0.451MG,0.451MG | tablet | Marketed | Bayer Hlthcare |
| SyedaCombination | United States | 3MG; 0.03MG | tablet | Marketed | Xiromed |
| YasminCombination | United States | 3MG; 0.03MG | tablet | Marketed | Bayer Hlthcare |
| YazCombination | United States | 3MG; 0.02MG | tablet | Marketed | Bayer Hlthcare |
| MelamisaCombination | United States | 3MG; 0.02MG | tablet | Marketed | Novast Labs |
| NikkiCombination | United States | 3MG; 0.02MG | tablet | Marketed | Lupin |
| Slynd | United States | 4MG | tablet | Marketed | Exeltis USA INC |
| TydemyCombination | United States | 3MG,N/A; 0.03MG,N/A; 0.451MG,0.451MG | tablet | Marketed | Lupin |
| YaelaCombination | United States | 3MG; 0.03MG | tablet | Marketed | Novast Labs |
| KemeyaCombination | United States | 3MG; 0.03MG | tablet | Not marketed | Sun Pharm |
| KyraCombination | United States | 3MG; 0.02MG | tablet | Not marketed | Sun Pharm |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
